---

Nicholas A. Peppas

Professor and Director of the Institute for Biomaterials, Drug Delivery and Regenerative Medicine, The University of Texas at Austin

“This has been a banner year for my team, with achievements including our new treatment for hemophilia using oral delivery of hematological factor IX, and our work developing drug delivery systems of siRNA and interferons. I am driven by a continuous excitement to devise new treatments, new therapeutic agents, and new medical devices that will help patients who suffer from debilitating diseases. I am particularly interested in understanding the mechanisms and providing innovative treatments for autoimmune diseases.”

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018